1. Home
  2. NPWR vs PCRX Comparison

NPWR vs PCRX Comparison

Compare NPWR & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NET Power Inc.

NPWR

NET Power Inc.

HOLD

Current Price

$2.33

Market Cap

285.1M

Sector

Energy

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.30

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NPWR
PCRX
Founded
2010
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
285.1M
1.0B
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
NPWR
PCRX
Price
$2.33
$26.30
Analyst Decision
Buy
Strong Buy
Analyst Count
2
7
Target Price
$3.50
$32.86
AVG Volume (30 Days)
881.3K
916.7K
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.47
Revenue
N/A
$716,791,000.00
Revenue This Year
N/A
$6.24
Revenue Next Year
N/A
$9.53
P/E Ratio
N/A
$55.91
Revenue Growth
42.86
3.14
52 Week Low
$1.48
$18.17
52 Week High
$11.83
$27.64

Technical Indicators

Market Signals
Indicator
NPWR
PCRX
Relative Strength Index (RSI) 33.90 64.48
Support Level $2.30 $25.48
Resistance Level $2.56 $27.16
Average True Range (ATR) 0.18 1.00
MACD -0.02 0.15
Stochastic Oscillator 0.71 77.18

Price Performance

Historical Comparison
NPWR
PCRX

About NPWR NET Power Inc.

NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: